AU506542B2 - 1, 3-dialkyl-7-oxoalkylxanthines - Google Patents

1, 3-dialkyl-7-oxoalkylxanthines

Info

Publication number
AU506542B2
AU506542B2 AU11338/76A AU1133876A AU506542B2 AU 506542 B2 AU506542 B2 AU 506542B2 AU 11338/76 A AU11338/76 A AU 11338/76A AU 1133876 A AU1133876 A AU 1133876A AU 506542 B2 AU506542 B2 AU 506542B2
Authority
AU
Australia
Prior art keywords
oxoalkylxanthines
dialkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU11338/76A
Other languages
English (en)
Other versions
AU1133876A (en
Inventor
J Goring
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wulfing Ja
Original Assignee
Wuelfing J A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuelfing J A filed Critical Wuelfing J A
Publication of AU1133876A publication Critical patent/AU1133876A/en
Application granted granted Critical
Publication of AU506542B2 publication Critical patent/AU506542B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU11338/76A 1975-02-21 1976-02-23 1, 3-dialkyl-7-oxoalkylxanthines Expired AU506542B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19752507555 DE2507555A1 (de) 1975-02-21 1975-02-21 7-(oxoalkyl)-1,3-dialkylxanthine, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel
DEDE250755 1975-02-21

Publications (2)

Publication Number Publication Date
AU1133876A AU1133876A (en) 1977-09-01
AU506542B2 true AU506542B2 (en) 1980-01-10

Family

ID=5939491

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11338/76A Expired AU506542B2 (en) 1975-02-21 1976-02-23 1, 3-dialkyl-7-oxoalkylxanthines

Country Status (18)

Country Link
JP (1) JPS51110598A (xx)
AR (2) AR208755A1 (xx)
AT (1) AT342617B (xx)
AU (1) AU506542B2 (xx)
BE (1) BE838466A (xx)
CH (1) CH621789A5 (xx)
DE (1) DE2507555A1 (xx)
DK (1) DK72676A (xx)
ES (1) ES445301A1 (xx)
FI (1) FI760418A (xx)
FR (1) FR2301258A1 (xx)
GB (1) GB1496316A (xx)
HU (1) HU174656B (xx)
IE (1) IE43978B1 (xx)
NL (1) NL7601622A (xx)
SE (1) SE7601455L (xx)
YU (1) YU37276A (xx)
ZA (1) ZA76568B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2761863A (en) * 1956-09-04 Lower-alkyl
DE932489C (de) * 1953-09-11 1955-09-01 Hoffmann La Roche Verfahren zur Herstellung von neuen Xanthinbasen und deren Salzen
CH325292A (de) * 1953-10-21 1957-10-31 Geigy Ag J R Verfahren zur Herstellung von 7-Oxyalkyl-xanthinderivaten
US3422107A (en) * 1964-09-05 1969-01-14 Albert Ag Chem Werke Certain oxoalkyldimethylxanthines and a process for the preparation thereof
DE1233405B (de) * 1964-09-05 1967-02-02 Albert Ag Chem Werke Verfahren zur Herstellung von 7-(Oxoalkyl)-1, 3-dimethylxanthinen
DE2234202A1 (de) * 1972-07-12 1974-01-24 Albert Ag Chem Werke Verfahren zur herstellung von oxoalkylxanthinen
DE2330742C2 (de) * 1973-06-16 1982-07-29 Hoechst Ag, 6000 Frankfurt 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
CH608236A5 (xx) * 1974-01-22 1978-12-29 Wuelfing J A Fa

Also Published As

Publication number Publication date
CH621789A5 (en) 1981-02-27
GB1496316A (en) 1977-12-30
AR208755A1 (es) 1977-02-28
AR210168A1 (es) 1977-06-30
DK72676A (da) 1976-08-22
ATA89776A (de) 1977-08-15
FI760418A (xx) 1976-08-22
JPS51110598A (xx) 1976-09-30
FR2301258A1 (fr) 1976-09-17
DE2507555A1 (de) 1976-09-02
HU174656B (hu) 1980-02-28
YU37276A (en) 1982-08-31
NL7601622A (nl) 1976-08-24
BE838466A (fr) 1976-08-11
SE7601455L (sv) 1976-08-22
ES445301A1 (es) 1977-06-01
ZA76568B (en) 1977-01-26
AU1133876A (en) 1977-09-01
AT342617B (de) 1978-04-10
FR2301258B1 (xx) 1978-11-17
IE43978L (en) 1976-08-21
IE43978B1 (en) 1981-07-15

Similar Documents

Publication Publication Date Title
PH20254A (en) 1,2 dihydro-2-oxo-(pyridiny,) nicotinanide
AU510273B2 (en) 103-dihydroimidazo (4,5-6) pyridin -2-ones
AU504595B2 (en) 4,5-dihydro-2-lower-alkoxycarbonyl-amino-4 phenylimidazoles
AU498333B2 (en) 7-substituted-benzo-1, 2, 4-triazine-3-ethers
AU507882B2 (en) 1, 4-diphenyl-3-pyrazolin-5-ones
AU511134B2 (en) 3-Isoxazolylcarbamoyl-l, 2-benzothianzine 1, 1-dioxide
AU1214076A (en) 2,3-dihalogen-alkanoyl-ureas
AU502683B2 (en) Thiopyrano-4, 3-c-pyrazoles
AU500164B2 (en) 3, 4, 5-substituted benzenesulfonformamidines
AU518594B2 (en) 15, 15-dihydroxyprostaglandins
AU505725B2 (en) 2, 9-dioxatricyclo ( 4,3,1,03,70 dercanes
AU505161B2 (en) 1, 3, 5, 7-tetraaza-4-sulpha-hept-1-en-6-one derivatives
AU499442B2 (en) 1, 4 benzodioxanes
AU502268B2 (en) 2, 1, 3-benzothiadiazine compounds
AU511156B2 (en) 7, 7-Dimethylnorbornane derivatives
AU504998B2 (en) 1, 3, 5 oxadiazine derivatives
AU500501B2 (en) 6,11-dihydrodibenzo-thiepin-11-ones
AU1724576A (en) 2,4-diamino-5-benzylpyrimidines
AU1483576A (en) 16,16-dimethyl-prostaglandins
AU506542B2 (en) 1, 3-dialkyl-7-oxoalkylxanthines
AU514608B2 (en) 3,4-substituted-azetidin-z-ones
AU506523B2 (en) 1, 3-Dialkyl-7-oxoalkylaxanthines
AU493823B2 (en) 1,1-diaryl-1-oxadiazol-alkylamines
AU506546B2 (en) 3, 20-diketopregnenes having an 11b-acetal groups
AU494288B2 (en) 2-tetrahydrofurfuryl-6, 7-benzomorphanes